The Margin podcast cover art

The Margin · Medical

How to Sell Your ASC: Timing, Preparation and What the Data Room Needs

Episode 36 · November 4, 2026 · 9 min

ASC valuations in 2027 hinge on one thing buyers trust more than revenue: proof of margin. This episode breaks down current EBITDA multiples, the regulatory shifts reshaping demand, and the exact data room documents that separate a clean sale from a discounted one.

Chapters:
0:06 Cold Open
0:47 Why This Market Is Different
2:01 What Actually Moves The Multiple
3:13 Clean Up Before You List
4:31 What The Data Room Needs
5:54 Who Buys And What They Want
6:44 What To Do This Quarter
7:57 Close

Free guide, The 2027 ASC State of the Union: https://sigmatic.ai/guide
Book a free consultation: https://sigmatic.ai/contact

#asc #surgerycenter #ambulatorysurgery #healthcarefinance #orutilization #ascsale #surgerycenters #healthcarevaluation #mergersandacquisitions #medicarereform

Chapters

  1. 00:06 Cold Open
  2. 00:47 Why This Market Is Different
  3. 02:01 What Actually Moves The Multiple
  4. 03:13 Clean Up Before You List
  5. 04:31 What The Data Room Needs
  6. 05:54 Who Buys And What They Want
  7. 06:44 What To Do This Quarter
  8. 07:57 Close

Transcript

Read the full transcript Every episode is transcribed, searchable, and quotable. Plain text

Sigmatic: Here's a number that matters more than your revenue line if you're ever planning to sell. Single specialty surgery centers are trading somewhere between five and eight times E B I T D A right now. Multi specialty centers, six to ten times. And platforms, the groups that own several centers, are going for eleven to seventeen times. That's a huge spread. And the thing that moves you from the bottom of your range to the top isn't how big you are. It's your margin. And here's the part that should bother you a little. Most sellers can't actually prove their margin to a buyer's satisfaction. Not because the margin isn't real, but because nobody ever built the file that shows it.

Sigmatic: Let's talk about why 2027 looks nothing like 2022, because the backdrop matters for timing a sale. The twenty twenty six Medicare rule added five hundred sixty procedures to the covered list for A S Cs, two hundred seventy-one of those pulled straight off the inpatient only list, plus thirty-five ancillary services on top. That's new addressable volume, and buyers are pricing it into your center before they even open your income statement. On top of that, site neutral payment policy is pushing Medicare toward paying the same rate for the same procedure no matter where it happens, hospital outpatient department or A S C. That narrows the gap between the two settings, and it's making hospital systems a lot more interested in buying or partnering with A S C capacity instead of fighting it. Add it up. The U S A S C market is sitting around forty-five point three billion dollars in twenty twenty five, and it's projected to hit seventy-two point seven billion by twenty thirty-three, growing at about six point one percent a year. And search interest in surgery centers hit a five year high in twenty twenty-six, up about a quarter over the previous few years. More buyers, more physician owners thinking about retirement, roughly the same moment. That's not a coincidence you can ignore.

Sigmatic: So if size isn't the main lever, what is. Margin, and it varies more by size than almost anything else in this business. Centers under three million dollars in revenue run around twelve point eight percent E B I T D A margin. Centers over nine million run closer to thirty-seven point three percent. That gap is enormous, and a buyer isn't paying for your revenue number at all. They're paying for your margin, and for their own guess about how much of the distance between your number and that thirty-seven percent benchmark is fixable after they close. Here's the thing though. If you can show them the fix already happened, under your ownership, with your own data, you're selling them a result. If you can't, you're asking them to believe a thesis, and buyers discount theses. Hard. The two line items that separate a thirteen percent margin center from a thirty-seven percent one are supplies and staffing, full stop. That's where a diligence team goes first, cost per case, by procedure, by surgeon, before almost anything else. We've got a separate piece that walks through how A S C economics work and who typically owns these centers if you want the fuller background. The links are in the blog, click over and check them out.

Sigmatic: There are three things that slow down or discount almost every sale we've seen, and all three are fixable months before you go to market, not in a weekend before a letter of intent shows up. First, certificate of need exposure. Thirty-five states, plus the District of Columbia, run some version of a certificate of need program, though several of them exempt A S Cs or apply a lighter review. A buyer needs to know your state's rule before they can model adding rooms or a new service line. Second, your compliance and licensing history. State license status, your Medicare conditions for coverage, accreditation survey history, any corrective action plans, all of that gets requested in round one of diligence. Centers that keep this current don't lose weeks to it mid deal. We've got a full compliance checklist covering licensing, Medicare conditions for coverage and life safety, the links are below, I will put them in the show notes. Third, if a management company runs your center, their fee, commonly four to seven percent of net revenue plus an equity stake, and the term of that agreement both get priced into the deal. The buyer inherits or renegotiates that contract, so know what it actually says about assignment and termination before someone else asks you to explain it on the spot.

Sigmatic: Here's where most sellers get it wrong. A data room built from your billing system's standard export is not the same thing as a data room built to answer the buyer's real question, which is, where is the margin, and how much of it is yours versus the market's. The difference is case level detail. You want three years of financials plus year to date, reconciled to tax returns. Contribution margin by procedure, by surgeon, and by payer, built from actual consumption data, not preference cards. Payer contracts with the effective rates you're actually getting paid, not the published fee schedule, with volume by payer for the past twelve months. Block utilization, first case on time start rate, and turnover time by surgeon for at least four quarters. Supply cost per case for your top twenty procedures by volume, with implant pricing broken out separately. Denial rate and days in accounts receivable with an aging schedule. And your licensing, accreditation survey history, and A S C quality reporting submission record. That last one surprises people. If you miss the A S C quality reporting requirements, you lose two percentage points off your annual payment update. A buyer who finds that gap in diligence discounts you twice, once for the lost rate, and once for what it tells them about how tight your operation really is.

Sigmatic: Not every buyer wants the same thing, so it helps to know who's across the table. Health systems buying A S C capacity are usually solving for referral stability and their own response to site neutral payment pressure. They'll pay for surgeon loyalty and a clean compliance file more than for raw E B I T D A growth. Management company platforms are solving for scale, and they will put your cost per case up against their existing book of centers you've never seen and can't explain, line by line. Private equity platforms want both of those things, plus a credible story for margin improvement after they close, and that story is a lot easier to sell if you've already shown the first round of improvement yourself, using the same case costing method their diligence team is going to run on you anyway.

Sigmatic: You don't need a letter of intent on the table to start any of this. Whether you sell next year or in five years, three things to do this quarter. Build contribution margin by procedure, surgeon, and payer for your top twenty procedures, using actual consumption data instead of preference cards. This is the single document every diligence team asks for first, so get ahead of it. Pull your A S C quality reporting submission history and your state license and accreditation file into one folder, and fix any gap now, while it's just a compliance task and not a negotiating point in someone else's diligence process. And read your management agreement, if you have one, for its assignment and termination language, and confirm your state's certificate of need rule for your center type before you talk to anybody about a sale. Most owners only run one sale process in their whole career. A banker who runs several a year knows the current range for your specialty mix, and bringing in help to build the data room is almost always cheaper than the discount a buyer applies for a messy one. We've got a piece on when to hire a consultant, what to ask, and what it should cost, the links are in the show notes.

Sigmatic: The margin conversation doesn't start when you're ready to sell. It starts with whether you can prove the margin you already have. That's really the whole episode in one sentence. If you want to make your A S C more profitable, book a free consultation with us at sigmatic dot A I. And grab our free guide, the twenty twenty-seven A S C State of the Union, it pulls together a lot of what we talked about today in one place. The links are in the show notes. Thanks for spending this time with us on The Margin. We'll see you next episode.

After the episode

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.